Home


Future Product Focus

During the next 12 to 24 months Braasch will focus on specific new vaccine products that address problems in:

Human Health

  • Myocardial Infarction Treatment.
  • Diabetes Applications.
  • Specific Neurological Treatments for IGF-1 responsive disorders.

    Copyright © 2010 Braasch Biotech LLC. All rights reserved.
    Webmaster

News and Releases



August 31, 2009

  • New Braasch Biotech Vaccine Technology Provides Growth Hormone and IGF-1 Treatments without the use of drugs


  • New Braasch Biotech Vaccine Technology Promises Greater Livestock Productivity and Obesity Treatment without drugs